Profound Medical Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Profound Medical Corp. generated cash of -$22,297,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,464,000 last year. Net change in cash is therefore -$20,304,000.
Cash Flow
| 2014 | -2.87M | -61.28K | 2.74M |
|---|---|---|---|
| 2015 | -4.94M | -6.49M | 18.72M |
| 2016 | -10.78M | 6.63M | 11.82M |
| 2017 | -11.81M | -793.18K | 6.12M |
| 2018 | -13.43M | 0 | 27.81M |
| 2019 | -15.33M | -191.38K | 6.74M |
| 2020 | -20.57M | -350K | 87.43M |
| 2021 | -22.36M | -593K | 5.94M |
| 2022 | -25.8M | 0 | 7.03M |
| 2023 | -22.29M | 0 | 1.46M |
PROF Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 46.51M | 67.15M | 83.91M | 14.8M | 23.49M | 8.15M | 16.56M | 7.82M | 292.92K | 605.89K |
Operating activities | ||||||||||
Net income | -28.56M | -28.66M | -30.69M | -21.62M | -15.45M | -15.24M | -14.96M | -12.14M | -11.80M | -8.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.14M | 1.60M | 1.87M | 1.53M | 1.54M | 1.22M | 693.31K | 139.13K | 85.77K | 84.89K |
Stock-based compensation expense | 3.41M | 4.23M | 7.20M | 3.01M | 1.28M | 0 | 1.06M | 745.15K | 464.60K | 190.33K |
| Deferred income tax benefit | 3.41M | 4.23M | 7.20M | 3.01M | 1.28M | 0 | 1.06M | 745.15K | 464.60K | 190.33K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.41M | -1.92M | 1.99M | -4.02M | -1.05M | 1.14M | -3.16M | -611.90K | 1.10M | 0 |
Inventories | 353K | -1.86M | -2.49M | -2.14M | -867.22K | -1.61M | -806.62K | -310.11K | 0 | 0 |
Accounts payable | 1.35M | -566K | -356K | 102K | -18.49K | -857.05K | 2.67M | 577.17K | -65.16K | 0 |
Cash generated by operating activities | -22.29M | -25.8M | -22.36M | -20.57M | -15.33M | -13.43M | -11.81M | -10.78M | -4.94M | -2.87M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.20M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -593K | -350K | -191.38K | 0 | -369.50K | -808.84K | -120.35K | -61.28K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | -423.68K | 0 | 834.14K | 0 |
Cash generated by investing activities | 0 | 0 | -593K | -350K | -191.38K | 0 | -793.18K | 6.63M | -6.49M | -61.28K |
Financing activities | ||||||||||
Common Stock Issued | 3.60M | 342.38K | 6.37M | 85.52M | 8.70M | 25.32M | 7.95M | 12.94M | 17.30M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.20M | 6.91M | -386K | -9.60M | -1.25M | -4.29M | -2.28M | -213.30K | 1.97M | -500K |
Cash used in financing activities | 1.46M | 7.03M | 5.94M | 87.43M | 6.74M | 27.81M | 6.12M | 11.82M | 18.72M | 2.74M |
Net Change In Cash | -20.30M | -20.63M | -16.76M | 69.11M | -8.77M | 14.37M | -7.73M | 7.67M | 7.28M | 2.74M |
Cash at end of period | 26.21M | 46.51M | 67.15M | 83.91M | 14.71M | 22.53M | 8.82M | 15.49M | 7.58M | 3.34M |
| Data source | Data source | Data source | Data source | Data source |